Zambian authorities say this precautionary measure will be reviewed based on how the outbreak in South Africa evolves.
While the resumption of local vaccine manufacturing marks a turning point, South Africa’s production capacity will initially remain limited.
The government is betting that swift action, long-term investment in vaccine production and stricter biosecurity will help contain FMD and restore stability to one of South Africa’s most valuable agricultural sectors.
While the situation right now is dire, South Africa hopes to ultimately achieve an FMD-free status without vaccination.
Foot-and-mouth disease is a serious transboundary animal disease that deeply affects the production of livestock and disrupts regional and international trade in animals and animal products.
South Africa, which has zones free of FMD without vaccination, faces growing calls from producers to declare a “state of disaster” to mitigate the economic fallout.
In response, the Department of Agriculture, Land Reform and Rural Development (DALRRD) has ordered over 900,000 doses of FMD vaccines, with the first batch expected to arrive next week.
The suspension is particularly significant given that China is South Africa’s top destination for beef exports by volume.
The platform introduced dedicated FMD vaccine record-keeping functionality in May to create a centralised and auditable record of vaccination activities.
The allegation against OBP is that it bought FMD vaccines from Biogénesis at R45 (US$2.81) per dose and sold them for between R70 (US$4.37) and R130 (US$8.12) per dose.